Medicines Stock Hits New 52-Week High (MDCO)

NEW YORK ( TheStreet) -- Medicines (Nasdaq: MDCO) hit a new 52-week high Tuesday as it is currently trading at $20.10, above its previous 52-week high of $20 with 324,990 shares traded as of 1:19 p.m. ET. Average volume has been 463,900 shares over the past 30 days.

Medicines has a market cap of $1.02 billion and is part of the health care sector and drugs industry. Shares are up 6.5% year to date as of the close of trading on Monday.

The Medicines Company, a global pharmaceutical company, provides various medicines to hospitals for advancing the treatment of critical care patients primarily in the United States and Europe. The company has a P/E ratio of 7.8, above the average drugs industry P/E ratio of six and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Medicines as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and solid stock price performance. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full Medicines Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Baidu Stock Plummets After COO Qi Lu Resignation

Baidu Stock Plummets After COO Qi Lu Resignation

Wondering What Blockchain Technology Really Is? This Expert Explains It All

Wondering What Blockchain Technology Really Is? This Expert Explains It All

Dow Rises Sharply as U.S.-China Trade Tensions Thaw

Dow Rises Sharply as U.S.-China Trade Tensions Thaw

GE Confirms $11.1 Billion Transportation Merger With Wabtec

GE Confirms $11.1 Billion Transportation Merger With Wabtec

Gold Prices Look 'Rich' at Current Levels - Here's What Could Change That

Gold Prices Look 'Rich' at Current Levels - Here's What Could Change That